LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer
Qinfeng Zhou, Xinyi Tang, Xinyu Tian, Jie Tian, Yue Zhang, Jie Ma, Huaxi Xu, Shengjun Wang · Journal of Cancer · 2018
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2018
Abstract
Myeloid-derived suppressor cells (MDSCs) have strong immunosuppressive functions and contribute to the formation of the tumor microenvironment.Long non-coding (Lnc) RNAs are highly important factors associated with tumors and may be used as markers for tumor diagnosis, which is valuable for targeted therapy.LncRNA MALAT1 is expressed in various tissues and plays a critical role in cell proliferation, including tumorigenesis and metastasis.However, the role of MALAT1 in MDSCs is unclear.In this study, we observed an increased proportion of MDSCs and elevated levels of the related molecule arginase-1 (ARG-1) in peripheral blood mononuclear cells (PBMCs) obtained from lung cancer patients.The proportion of CD8 + cytotoxic T lymphocyte (CTL) was significantly decreased in PBMCs from lung cancer patients.Moreover, the proportion of CTL cells was negatively correlated with the proportion of MDSCs.Furthermore, MALAT1 levels were decreased in PBMCs from lung cancer patients.The relative expression of MALAT1 was moderate negatively correlated with the proportion of MDSCs.In vitro results indicate that the knockdown of MALAT1 significantly increased the proportion of MDSCs.Our data provide the first evidence that lncRNA MALAT1 negatively regulates MDSCs and is decreased in PBMCs from lung cancer patients.
Open the resolved locator · 10.7150/jca.24796
Metadata licence: OpenAlex metadata (CC0)